Mahamaya Lifesciences
BSE SME₹2,73,600 / Individual : 2400 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 13 Nov 2025, 06:57 PM |
| QIBs | 1.19 times |
| NII | 2.95 times |
| Total | 1.59 times |
Mahamaya Lifesciences IPO Details
The Mahamaya Lifesciences IPO price band is set between ₹108-114 per equity share, with a face value of ₹10 per share. The issue is managed by Kfin Technologies Ltd, and the equity shares are proposed to be listed on the BSE SME.
The IPO date for subscription opens on 11 Nov, 2025 and closes on 13 Nov, 2025. Investors can check the allotment status on 14 Nov, 2025, while the listing date is tentatively scheduled for 18 Nov, 2025.
The total issue size is 61,78,800 shares, aggregating up to ₹70.44 crore. Stay tuned for the latest Mahamaya Lifesciences IPO review and GMP updates.
Mahamaya Lifesciences IPO Review, Rating & Analysis
Mahamaya Lifesciences IPO Review
NO REVIEWMahamaya Lifesciences IPO Rating
Mahamaya Lifesciences IPO Highlights
IPO Date
Nov 11, 2025 - Nov 13, 2025
Listing Date
18 Nov, 2025
Face Value
₹10 Per Equity Share
Price Band
₹108-114 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE SME
Mahamaya Lifesciences IPO Lot Size
The minimum market lot for Mahamaya Lifesciences IPO is 2400 shares with an application amount of ₹2,73,600. Retail investors can apply for up to 0 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2400 | ₹2,73,600 |
| Retail (Max) | 0 | 0 | ₹0 |
| S-HNI (Min) | 1 | 2400 | ₹2,73,600 |
| S-HNI (Max) | 3 | 7200 | ₹8,20,800 |
| B-HNI (Min) | 4 | 9600 | ₹10,94,400 |
Mahamaya Lifesciences IPO Timeline
Issue Price
₹108-114 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE SMERegistrar
Kfin Technologies LtdLead Manager
Oneview Corporate Advisors Pvt.LtdIssue Size
61,78,800 shares(aggregating up to ₹70.44 crore)Mahamaya Lifesciences IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 30-Jun-25 | 218.87 | 84.04 | 4.10 | 53.50 | 35.73 | 57.72 |
| 31-Mar-25 | 188.35 | 267.17 | 12.94 | 49.42 | 31.66 | 58.11 |
| 31-Mar-24 | 112.07 | 162.83 | 5.22 | 24.66 | 23.41 | 54.63 |
| 31-Mar-23 | 77.88 | 137.40 | 3.75 | 19.44 | 18.19 | 24.37 |
In Cr.
Mahamaya Lifesciences IPO Reservation Details
| Investor Category | Shares Offered | % Shares |
|---|---|---|
| Anchor Investor Shares Offered | 17,52,000 | 28.36% |
| Market Maker Shares Offered | 3,09,600 | 5.01% |
| QIB Shares Offered | 11,76,000 | 19.03% |
| NII (HNI) Shares Offered | 11,91,600 | 14.27% |
| bNII > ₹10L | 5,88,000 | 9.52% |
| sNII < ₹10L | 2,94,000 | 4.76% |
| Individual Shares Offered | 20,59,200 | 33.33% |
| Total Shares Offered | 61,78,800 | 100% |
Mahamaya Lifesciences IPO Documents
Mahamaya Lifesciences IPO Valuations
EPS Pre IPO
₹7.29/-EPS Post IPO
₹7.01/-PE Pre IPO
15.65PE Post IPO
16.25ROE
34.94%ROCE
23.15%Debt Equity
1.08RoNW
26.19%PAT Margin
4.84%Price to Book Value
9.40Promoters & Share Holding
Promoter(s) Name
- Mr. Krishnamurthy Ganesan
- Mrs. Lalitha Krishnamurthy
- Mr. Prashant Krishnamurthy
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 77.27% | 56.35% |
About Company
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.
The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.
The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Mahamaya Lifesciences IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 11,76,000 / 8,82,000 | <span>
20,59,200
</span> | 41,17,200 | |
Day 111-11-25 06:00 PM | 0.00 / 0.35 x | <span>
0.07
x
</span> | 0.11 x | |
Day 212-11-25 06:00 PM | 0.65 / 0.27 x | <span>
0.20
x
</span> | 0.34 x | |
Day 313-11-25 06:00 PM | 1.19 / 2.95 x | <span>
1.02
x
</span> | 1.59 x |
Mahamaya Lifesciences IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Purchase of Equipment for existing Formulation plant | - |
| Funding capital expenditure towards setting up of a new technical manufacturing plant | - |
| Construction of Warehouse Building and Purchase of Machinery | - |
| Funding working capital requirement of our Company | - |
| General corporate purposes | - |
Company Contact Details
Mahamaya Lifesciences
Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1, Delhi, New Delhi, 110020Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: mahamaya.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Frequently Asked Questions about Mahamaya Lifesciences IPO
When will Mahamaya Lifesciences IPO open for subscription?
The Mahamaya Lifesciences IPO opens on 11 Nov, 2025 and closes on 13 Nov, 2025.
What is the investors portion for Mahamaya Lifesciences IPO?
The investors' portion for QIB is 1.19 2.95 x, NII is 1.02 x, and Retail is .
How to apply for Mahamaya Lifesciences IPO?
You can apply for Mahamaya Lifesciences IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Mahamaya Lifesciences IPO?
The issue size of Mahamaya Lifesciences IPO is approx ₹61,78,800 shares(aggregating up to ₹70.44 crore) crores.
What is the price band of Mahamaya Lifesciences IPO?
The price band for Mahamaya Lifesciences IPO is ₹108 to ₹114 per equity share.
What is the lot size of Mahamaya Lifesciences IPO?
The minimum bid (lot size) for Mahamaya Lifesciences IPO is 1200 shares with an investment of approx ₹2,73,600 .
What is the allotment date of Mahamaya Lifesciences IPO?
The allotment date for Mahamaya Lifesciences IPO is 14 Nov, 2025.
What is the listing date of Mahamaya Lifesciences IPO?
The listing date for Mahamaya Lifesciences IPO is expected to be 18 Nov, 2025.
What is the GMP of Mahamaya Lifesciences IPO?
The latest Grey Market Premium (GMP) for Mahamaya Lifesciences IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.